1 Day
Source:
الصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
1 Dayالصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
1 DayReady to play
Ready to play
A review of records for more than 256,000 adults with obesity and prediabetes, followed for three years, found that users of GLP-1 drugs were more likely than metformin users to return their blood sugar levels to normal—by 50%—and had a 31% lower risk of developing type 2 diabetes. These drugs were also associated with lower risks of death from any cause (41%), heart attacks (15%), strokes (20%), heart failure (25%), and atrial fibrillation (8%). Despite the findings, one researcher said metformin remains the first-line treatment because it is safe, inexpensive, and has a long track record of use.
Notice: This Is an AI-Generated Summary
Comments (0)